Form D · Biotechnology
TuHURA Biosciences, Inc.
Tampa, FL · CIK 0001252142
Offering snapshot reported Dec 27, 2023 · SEC filing
- Reported sold
- $1.67M Offering amount: $15M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 11, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 27, 2023 | Initial | $1,665,000 | No comparison | 8 | SEC filing |
| Jul 11, 2022 | Initial | $9,101,001 | No comparison | 2 | SEC filing |
| Nov 19, 2021 | Initial | $5,100,000 | No comparison | 4 | SEC filing |
| Sep 29, 2021 | Amendment | $3,830,130 | $1,150,571vs Dec 17, 2020 | 39 | SEC filing |
| Dec 17, 2020 | Initial | $2,679,559 | No comparison | 24 | SEC filing |
| Jul 3, 2019 | Initial | $495,000 | No comparison | 5 | SEC filing |
| Jan 12, 2018 | Amendment | $2,708,818 | $951,604vs Aug 21, 2017 | 40 | SEC filing |
| Aug 21, 2017 | Initial | $1,757,214 | No comparison | 6 | SEC filing |
| Apr 7, 2017 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Nov 4, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $133K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-500849
Paulson Investment Company, LLC ("Paulson") will be paid a cash placement fee equal to 6% of gross proceeds of Offering. Issuer will also issue to Paulson a number of shares of Common Stock equal to 2% of the gross proceeds of Offering divided by 1.5.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Paulson Investment Company LLC | 5670 |
Source: Form D, filed Dec 27, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Bergmann | Director |
| James Bianco | Director, Executive |
| Grahame Cook | Director |
| Daniel Dearborn | Executive |
| Dan Dearborn | Executive |
| Joseph Errico | Director |
| David Lawman | Director |
| Michael Lawman | Director |
| Patricia Lawman | Director |
| Alan List | Director |
| James Manuso | Director |
| James Mc Nulty | Director |
| George Ng | Director |
| Kiran Patel | Director |
| Michael Shamblott | Executive |
| Scott Slayton | Executive |
| Peter Staats | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10500 University Center Drive
Tampa, FL, 33612
Tampa, FL, 33612